Weight loss interventions had significant effects on NAFLD‐related parameters including glucose, insulin, HOMA‐IR, weight, BMI, BMI z‐score, WC, TG, and AST. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.